期刊文献+

氨氯地平联合氯沙坦钾治疗老年难治性高血压患者的疗效 被引量:5

下载PDF
导出
摘要 目的探讨氨氯地平联合氯沙坦钾治疗老年难治性高血压患者的临床疗效。方法将2016年6月至2017年10月收治的152例老年难治性高血压患者随机分为试验组和对照组,各76例。两组均予以氢氯噻嗪、美托洛尔等基础治疗,对照组加以氨氯地平治疗,试验组加以氨氯地平联合氯沙坦钾治疗,对比分析治疗前后两组的血压变化情况及两组的临床疗效。结果治疗前,两组收缩压和舒张压比较,差异无统计学意义(P>0.05)。治疗后,试验组的收缩压、舒张压均低于对照组,差异有统计学意义(P<0.05)。试验组治疗有效率为86.84%,高于对照组的71.05%,差异有统计学意义(P<0.05)。结论在老年难治性高血压患者中施以氨氯地平联合氯沙坦钾治疗,可有效控制患者的血压,并能有效提高临床疗效。
作者 常姝丽
出处 《医疗装备》 2018年第9期121-122,共2页 Medical Equipment
  • 相关文献

参考文献4

二级参考文献25

  • 1唐渝平,李婷婷.海捷亚和氨氯地平治疗原发性高血压的疗效及对尿微量蛋白的影响[J].心肺血管病杂志,2005,24(2):94-95. 被引量:7
  • 2Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment, a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research [ J ]. Hyperten- sion, 2008,51 ( 6 ) : 1403-1419.
  • 3Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evalua- tion, and Treatment of High Blood Pressure [ J]. Hypertension, 2003,42(6) :1206-1252.
  • 4Shimbo D, Levitan EB, Booth JN 3rd, et al. The contributions of unhealthy lifestyle factors to apparent resistant hypertension: find- ings from the Reasons for Geographic And Racial Differences in Stroke (REGARDS) study [ J ]. J Hypertens, 2013,31 ( 2 ) : 370- 376.
  • 5Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESI-I) and of the European Society of Cardiology (ESC)[J]. J Hypertens, 2013,31 (7) :1281-1357.
  • 6Sarafidis PA. Epidemiology of resistant hypertension [ J ]. J Clin Hypertens ( Greenwich), 2011,13 (7) :523-528.
  • 7Muxfeldt ES, Fiszman R, de Souza F, et al. Appropriate time in- terval to repeat ambulatory blood pressure monitoring in patients with white-coat resistant hypertension[J]. Hypertension, 2012, 59(2) :384-389.
  • 8Duprez DA. Aldosterone and the vasculature: mechanisms media- ting resistant hypertension [ J ]. J Clin Hypertens ( Greenwich), 2007,9(1 Suppl 1) :13-18.
  • 9Gaddam KK, Nishizaka MK, Pratt-Ubunama MN, et al. Charac- terization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volumeex- pansion [ J ]. Arch Intern Med, 2008,168 ( 11 ) : 1159-1164.
  • 10Mann JF, Schmieder RE, McQueen M, et al. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk ( the ONTARGET study ) : a muhicentre, randomised, double- blind, controlled trial[J]. Lancet, 2008,372(9638) :547-553.

共引文献29

同被引文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部